All Articles
Coronary Artery Disease

  • Atherosclerosis image

    What is Atherosclerosis

    Overview

    Atherosclerosis is a chronic, slowly progressing disease where fatty and/or fibrous material builds up in the inner layer of your arteries, called the intima. This build-up forms what are known as atherosclerotic plaques or atheromas, a term derived from a Greek word, reflecting the appearance of the lipid material at the core of these plaques. Over time, these plaques can become more fibrous and accumulate calcium.

    This condition can have serious consequences by impeding blood flow, leading to ischemia (insufficient blood supply to tissues). Plaques can also break open, triggering the formation of a thrombus (blood clot) that can block the artery, causing acute ischemia.

    Coronary artery disease (CVD) is a leading cause of vascular disease and death worldwide, significantly contributing to conditions like heart attacks and strokes. Despite advancements in medical care, it remains a major global health challenge.

    In Details

    First: Key Characteristics of Atherosclerosis

    • Build up of fatty and fibrous material: Occurs in the inner lining of arteries.
    • Formation of plaques (atheromas): These are the distinctive lesions of the disease.
    • Narrowing of arteries: Advanced plaques can reduce the space for blood flow.
    • Risk of blood clot formation: Plaques can rupture or erode, leading to clots that block blood flow.
    • Involves Low-Density Lipoprotein (LDL): A key factor in plaque development.
    • Inflammation and other risk factors: Play significant roles in its development.

    Initiation of Atherosclerosis

    Atherosclerosis often begins as early as childhood, though symptoms may not appear for decades. The process is thought to start with damage or injury to the inner layer of an artery, called the endothelium. This damage can be caused by various factors, including high blood pressure, high cholesterol, high triglycerides (another type of fat in the blood), smoking or other tobacco use, diabetes, insulin resistance, obesity, and inflammation. When the artery wall is damaged, low-density lipoprotein (LDL) particles – which transport cholesterol through the blood – can accumulate in the intima, the innermost layer of the artery

    Research strongly suggests that atherosclerosis would likely not occur if LDL-C (low-density lipoprotein cholesterol) concentrations did not exceed the body’s physiological needs. Prolonged exposure to high LDL-C levels over many years is a primary driver of the disease’s initiation and progression. For instance, individuals with familial hypercholesterolaemia (a genetic condition causing very high LDL-C from an early age) develop premature atherosclerotic CVD, highlighting LDL’s causal role.

    Progression of Atherosclerosis

    In its early stages, atherosclerotic plaques often expand outwards, away from the arterial lumen (the hollow centre where blood flows), which helps preserve the artery’s width. However, eventually, the growing plaque begins to encroach upon the arterial lumen, leading to stenosis (narrowing) and potentially flow-limiting lesions. This reduced blood flow can cause symptoms like angina pectoris (chest pain from insufficient blood to the heart) during physical exertion.

    Complications of Atherosclerosis

    The most severe complications of atherosclerosis often arise from the disruption of plaques. The most common trigger for acute coronary syndromes, such as a myocardial infarction (heart attack), is the rupture of an atherosclerotic plaque.

    These “vulnerable plaques” typically have a large lipid core covered by a thin fibrous cap (a layer of fibrous tissue). When this cap breaks, the plaque’s thrombogenic (clot-forming) contents are exposed to the blood, rapidly triggering thrombosis (blood clot formation), which can completely block the artery.

    Another mechanism, increasingly recognized, is plaque erosion, where lesions without a thin cap or much lipid can also lead to clot formation, particularly in the current era of effective anti-atherosclerotic therapies. These clots can lead to acute ischemic events like heart attacks or strokes.

    Other Similar Questions

    What are the common symptoms of atherosclerosis?

    Mild atherosclerosis often causes no symptoms for many years. Symptoms usually only appear when an artery is significantly narrowed or blocked, or when a blood clot forms. Symptoms vary depending on which arteries are affected. For example, chest pain (angina) if it’s in heart arteries, sudden weakness or trouble speaking if it’s in brain arteries (like a stroke), or leg pain when walking (claudication) if it’s in leg arteries.

    Is atherosclerosis curable?

    While atherosclerosis is a chronic and progressive disease, its progression can often be prevented, and in some cases, even reversed, through lifestyle changes and medical treatments. Current treatments aim to manage the disease and prevent its serious complications like heart attacks and strokes.

    How is atherosclerosis diagnosed?

    The diagnosis of atherosclerosis often involves imaging tests that can directly visualise the plaques or assess if there is reduced blood flow to organs. Non-invasive tests include ultrasonography (using sound waves) and CT angiography (a type of X-ray scan).

    More invasive procedures like invasive angiography (using a dye to visualize arteries) might be used to guide treatments.

    Resources

    • “Atherosclerosis” by Peter Libby, Julie E. Buring, Lina Badimon, Göran K. Hansson, John Deanfield, Márcio Sommer Bittencourt, Lale Tokgözoğlu and Eldrin F. Lewis.
    • Arteriosclerosis / atherosclerosis
  • Prevention of Coronary Artery Disease image

    Prevention of Coronary Artery Disease

    Overview

    Prevention of Coronary Artery Disease by modifying what are called modifiable risk factors, which are factors you can change, such as diet, exercise, and smoking habits. Prevention is divided into three key categories: primary, secondary, and tertiary. These approaches aim to stop Coronary Artery Disease before it starts, slow its progression, or manage its impact to improve your quality of life.

    In Details

    • Primary Prevention: Aims to prevent Coronary Artery Disease before it even occurs, for people with risk factors but no symptoms.
    • Secondary Prevention: Focuses on people who already have established Coronary Artery Disease, to prevent further progression and reduce the impact of the disease.
    • Tertiary Prevention: Applies to people with existing Coronary Artery Disease, aiming to improve their quality of life by reducing disability, delaying complications, and restoring heart function.

    Risk factors for Coronary Artery Disease are broadly divided into non-modifiable and modifiable. Non-modifiable factors, which cannot be changed, include age, gender, race, and your genes.

    Modifiable risk factors, which you can influence, include dyslipidemia (unhealthy levels of fats in your blood), diabetes, hypertension, cigarette smoking, obesity, chronic kidney disease, chronic infection, high C-reactive protein (CRP) (a marker of inflammation), hyperhomocysteinemia (HHcy) (high levels of an amino acid called homocysteine), advanced glycation end products (AGEs), oxidative stress, and caffeine. Modifying these factors can prevent, reverse, or slow the progression of Coronary Artery Disease and improve your quality of life.

    Primary Prevention of Coronary Artery Disease 

    Primary prevention is about taking steps to prevent the start of atherosclerosis. This involves assessing your risk, especially if you are between 40 and 75 years of age.

    A Coronary Artery Disease risk score, like the one developed by the American College of Cardiology ASCVD risk estimator, considers factors such as age, sex, race, cholesterol levels, blood pressure, diabetes, smoking, and medication use to estimate your 10-year risk of having Coronary Artery Disease or a stroke. This score, expressed as a percentage, helps determine if you are at low (0.0-4.9%), borderline (5.0-7.4%), intermediate (7.5-20.0%), or high risk (>20.0%) and guides prevention strategies.

    Key interventions for primary prevention include

    • Adopting a Healthy Diet: This means consuming plenty of fruits, vegetables, nuts, whole grains, lean proteins (vegetable or animal), and fish.
      It’s advised to reduce intake of trans fats, red meat, processed meat, added sugars, saturated fat, sweetened beverages, and sodium. Foods like flaxseed, whey protein, and grapefruit (containing resveratrol) can help lower “bad cholesterol” and raise “good cholesterol”.
    • Managing AGE-RAGE Stress: AGEs are harmful compounds that can build up in the body and contribute to atherosclerosis. They are found in foods like red meat, cheese, cream, animal fat, and sweetened pastries, so reducing their consumption is advised.
    • Reducing Oxidative Stress: This occurs when there’s an imbalance between harmful reactive oxygen species (ROS) (unstable molecules that can damage cells) and your body’s antioxidants.
      Eating antioxidant-rich foods like flaxseed, fruits, and vegetables can help. Limiting heavy alcohol consumption is also recommended.
    • Regular Physical Activity: Aim for 150 minutes per week of moderate-intensity physical activity or 75 minutes per week of high-intensity physical activity.
    • Stopping Tobacco Use: Quitting smoking is crucial.
    • Controlling Diabetes and Hypertension: If you have diabetes, managing your diet, exercising, and taking medication as needed are important.
      For hypertension, non-pharmacological interventions are advised, and pharmacological therapy may be recommended to achieve a blood pressure target of less than 130/80 mmHg.
    • Aspirin Use: Infrequent use of aspirin may be advised.

    Secondary Prevention of Coronary Artery Disease

     Secondary prevention is for individuals who have already been diagnosed with Coronary Artery Disease, have current symptoms, or have experienced a heart attack, or undergone procedures like percutaneous coronary intervention (PCI) (a procedure to open blocked arteries, often using a balloon and stent) or coronary artery bypass graft (CABG) (a surgical procedure to create new pathways for blood flow around blocked arteries).
    The main goal is to slow or reverse the disease’s progression and reduce the risk of future events or death.

    Key interventions for secondary prevention include

    • Lifestyle Modification: This includes diet similar to primary prevention. Physical activity recommendations are similar, with a target of at least 150 minutes per week of moderate-intensity or 75 minutes per week of high-intensity physical activity. Stopping cigarette smoking is also critical.
    • Serum Lipids Management: Medications like statins are used to lower LDL-C. Fibrates or high doses of omega-3 fatty acids might be used if triglyceride (TG) levels are high.
    • Hypertension Management: Antihypertensive drugs may be used. Sodium and alcohol restriction are also important, with a blood pressure target of 130/80 mmHg.
    • Antiplatelet Drugs: If your 10-year risk score is 10% or higher, antiplatelet drugs like aspirin or clopidogrel may be used to prevent blood clotting.
    • Diabetes Management: The aim is to normalise blood glucose levels using antidiabetic drugs, with a target for HbA1c (a measure of average blood sugar over 2-3 months) of less than 7%.

    Tertiary Prevention of Coronary Artery Disease

     Tertiary prevention is for people with established Coronary Artery Disease, focusing on improving their quality of life by reducing disability, delaying or limiting complications, and restoring heart function.

    This involves a team approach with healthcare professionals like cardiologists, cardiac surgeons, exercise specialists, physiotherapists, dietitians, and nurses. Treatment often includes medical procedures such as PCI, CABG, pacemaker implantation, defibrillator placement, and ventricular-assisted devices.

    Other Similar Questions

    Is Coronary Artery Disease preventable in all cases?

    While it’s largely preventable through risk factor modification, some non-modifiable risk factors like age and genetics mean it might not be entirely avoidable for everyone, but its progression can be significantly slowed.

    Resources

  • Symptoms of Coronary Artery Disease image

    Symptoms of Coronary Artery Disease

    Overview

    Understanding these symptoms is crucial because early detection and management can significantly improve outcomes. The way Coronary Artery Disease presents can vary greatly among individuals, ranging from no noticeable symptoms to severe and life threatening events. It’s important to be aware of the different ways this condition can manifest, as recognizing them promptly can lead to timely medical attention.

    Symptoms of Coronary Artery Disease

    Here is a quick list of common symptoms associated with Coronary Artery Disease:

    • Chest pain or discomfort (Angina Pectoris)
    • Shortness of breath (Dyspnea)
    • Fatigue
    • Nausea
    • Sweating (Diaphoresis)
    • Fainting (Syncope)
    • Palpitations (a feeling of your heart pounding or racing)
    • Cardiac arrest or sudden cardiac death
    • Atypical symptoms, especially in women, the elderly, and diabetics
    • Silent ischemia (no symptoms at all)

    In Details:

    1. Angina pectoris

    The most common symptom of Coronary Artery Disease is angina pectoris, often simply called angina. This is a clinical syndrome characterized by discomfort in the chest. People often describe it as a tight, squeezing, heavy, or pressure like feeling, rather than a sharp pain. This discomfort can be felt in the center of the chest (substernal) and may spread or radiate to other areas, such as the jaw, shoulder, back, arms (especially the left arm, or both arms), or even the teeth and upper abdomen (epigastric region).

    Angina is typically brought on by increased demand on the heart, such as during physical exertion, emotional stress, after a heavy meal, or exposure to cold. It usually lasts for several minutes and can be relieved by rest or by taking medication like sublingual nitroglycerin.

    2. Dyspnea

    Another significant symptom is dyspnea, or shortness of breath. More commonly, shortness of breath occurs alongside chest discomfort, described as a feeling of tightness across the chest or a restriction in breathing. Dyspnea can also indicate more advanced Coronary Artery Disease, such as if there’s ischemic left ventricular dysfunction (when the heart’s main pumping chamber is weakened due to lack of blood flow), or other complications like pulmonary venous congestion or pulmonary oedema.

    3. General symptoms

    Beyond chest discomfort and breathlessness, Coronary Artery Disease can manifest with other general symptoms. These can include nausea, sweating (diaphoresis), and fatigue. Fatigue is particularly common in patients with Coronary Artery Disease, sometimes due to the psychological impact of the disease or when combined with cardiac failure. Some individuals might experience palpitations, a sensation of their heart pounding or racing, or episodes of syncope (fainting).

    4. Atypical symptoms

    It’s important to be aware of atypical symptoms, which are more frequently observed in certain populations like women, the elderly, and individuals with diabetes mellitus. In these groups, Coronary Artery Disease might not present with the classic chest pain. Instead, it could appear as isolated symptoms such as palpitations, extreme fatigue, unusual discomfort (e.g., in the neck, jaw, or back without chest pain), or even lead directly to cardiac arrest without prior noticeable signs. The diagnosis of these atypical presentations can be challenging and requires careful clinical assessment.

    5. Silent ischemia

    A particularly concerning aspect of Coronary Artery Disease is silent ischemia. This refers to episodes where the heart muscle is not receiving enough blood (ischemia) but the person experiences no pain or discomfort at all. This lack of symptoms means that significant heart damage can occur without any warning. Silent ischemia is more prevalent among the elderly and people with diabetes mellitus.

    In some tragic cases, the very first manifestation of Coronary Artery Disease is a heart attack (myocardial infarction), which can be fatal. In fact, for approximately one in four people, the first symptom of coronary artery disease is what is termed sudden cardiac death. In these instances, there may be no prior warning signs or symptoms at all. However, for some who experience cardiac arrest, there might have been “warning symptoms” like chest pain or dyspnea in the days or weeks leading up to the event.

    Other similar questions

    Can I have coronary artery disease without any symptoms?

    Yes, it is possible. Many individuals, especially the elderly and those with diabetes, can have what is called “silent ischemia,” where they experience reduced blood flow to the heart without any noticeable pain or discomfort

    Do men and women experience Coronary Artery Disease symptoms differently?

    While the core symptoms are similar, women, the elderly, and diabetics are more prone to “atypical symptoms” which might not include classic chest pain. These can manifest as fatigue, shortness of breath, nausea, or discomfort in areas like the jaw, neck, or back, rather than the chest.

    When to seek medical attention ?

    If you experience symptoms that suggest Coronary Artery Disease, such as chest pain or discomfort, shortness of breath, or unexplained fatigue, you should seek medical attention promptly. For severe or sudden symptoms like crushing chest pain, especially if it radiates or is accompanied by sweating or nausea, call for emergency medical help immediately.

    Resources

    • Malakar, A. K., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S. (2019). A review on coronary artery disease, its risk factors, and therapeutics. Journal of Cellular Physiology, 234(10), 16812–16824.
    • Bergmark, B. A., Mathenge, N., Merlini, P. A., Lawrence-Wright, M. B., & Giugliano, R. P. (2021). Acute coronary syndromes. The Lancet, 398(10300), 741–756.
    • Smith, J. N., Negrelli, J. M., Manek, M. B., Hawes, E. M., & Viera, A. J. (2015). Diagnosis and Management of Acute Coronary Syndrome: An Evidence-Based Update. Journal of the American Board of Family Medicine, 28(2), 283–293.
    • Geller, B. J., & Abella, B. S. (2018). Evolving Strategies in Cardiac Arrest Management. Cardiology Clinics, 36(1), 73–84.
    • Granfeldt, A. (2019). In-Hospital Cardiac Arrest. JAMA, 321(16), 1618-1619.
    • Krahn, A. D., Tfelt-Hansen, J., Tadros, R., Steinberg, C., Semsarian, C., & Han, H.-C. (2022). Latent Causes of Sudden Cardiac Arrest. JACC: Clinical Electrophysiology, 8(6), 806–821.
    • Gallone, G., Baldetti, L., Pagnesi, M., Latib, A., Colombo, A., Libby, P., & Giannini, F. (2018). Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome. Journal of the American College of Cardiology, 72(23), 2886–2903.
    • Bahit, M. C., Korjian, S., Daaboul, Y., Baron, S., Bhatt, D. L., Kalayci, A., Chi, G., Nara, P., Shaunik, A., & Gibson, C. M. (2023). Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review. Clinical Therapeutics, 45(9), 1119–1126.
    • Gaviria-Mendoza, A., Zapata-Carmona, J. A., Restrepo-Bastidas, A. A., Betancur-Pulgarín, C. L., & Machado-Alba, J. E. (2020). Prior Use of Medication for Primary Prevention in Patients with Coronary Syndrome. Journal of Primary Care & Community Health, 11, 2150132720946949.
    • Silverio, A., Cancro, F. P., Esposito, L., Bellino, M., D’Elia, D., Verdoia, M., Vassallo, M. G., Ciccarelli, M., Vecchione, C., Galasso, G., & De Luca, G. (2023). Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets. Journal of Clinical Medicine, 12(6), 2161.
    • Fitchett, D. H., Leiter, L. A., Lin, P., Pickering, J., Welsh, R., Stone, J., Gregoire, J., McFarlane, P., Langer, A., Gupta, A., & Goodman, S. G. (2020). Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome. CJC Open, 2(4), 402–415.
    • Isted, A., Williams, R., & Oakeshott, P. (2018). Secondary prevention following myocardial infarction: A clinical update. British Journal of General Practice, 68(669), 151–152.
    • Bavishi, A., Howard, T., Ho-Kim, J., Hiramato, B., Pierce, J. B., Mendapara, P., Alhalel, J., Wu, H.-W., Srdanovich, N., & Stone, N. (2018). Treatment Gap in Primary Prevention Patients Presenting with Acute Coronary Syndrome. The American Journal of Cardiology, 123(2), 237–242.
    • Sun, Z. (2013). Cardiac Imaging Modalities in the Diagnosis of Coronary Artery Disease. Journal of Clinical & Experimental Cardiology, S6(e001), 1–4.
    • Ford, T. J., & Berry, C. (2020). Angina: Contemporary diagnosis and management. Heart, 106(5), 387–398.
    • Libby, P., & Theroux, P. (2005). Pathophysiology of Coronary Artery Disease. Circulation, 111(25), 3481–3488.
    • Mayo Clinic. (n.d.). Coronary artery disease – Diagnosis and treatment. Retrieved from.
    • Albus, C., Barkhausen, J., Fleck, E., Haasenritter, J., Lindner, O., & Silber, S. (2017). The Diagnosis of Chronic Coronary Heart Disease. Deutsches Ärzteblatt International, 114(42), 712–719.
  • Complications of Coronary Artery Disease

    Complications of Coronary Artery Disease

    Overview

    Understanding the potential complications of Coronary Artery Disease is crucial for patients and their loved ones, as it highlights the importance of early diagnosis, effective management, and adopting healthy lifestyle.

    Coronary Artery Disease itself is an atherosclerotic disease, meaning it involves the buildup of plaque inside the arteries, which is inflammatory in nature. This plaque accumulation starts when the lining of the arterial wall is disrupted, leading to lipoprotein droplets gathering in the coronary vessels. Over time, these plaques can disrupt or erode, potentially leading to serious complications.

    In Detail
    Complications of Coronary Artery Disease

    Here’s a quick list of the main complications of Coronary Artery Disease:

    The manifestations and complications of Coronary Artery Disease can vary, from less severe symptoms to life threatening events.

    Angina Pectoris

    Angina Pectoris, or chest pain, is a common clinical syndrome associated with myocardial ischemia. This discomfort can be felt in the chest, jaw, arm, or other areas. While often described as a tight, squeezing, or heavy feeling, its localization can be vague, and there’s considerable individual variation. Angina can be stable, unstable, or even manifest as variant angina (Prinzmetal angina) or microvascular angina. It is important to know that many patients experiencing angina, about half, do not have obstructive coronary artery disease (blockages visible on angiography) but rather have microvascular angina (MVA), which involves problems with the very small blood vessels of the heart, and/or vasospastic angina (VSA), caused by sudden narrowing or spasm of the heart arteries. A critical point is that angina symptoms do not always directly correlate with the severity of the underlying atherosclerosis, and some patients can have considerable myocardial ischemia without any pain, a condition known as ‘silent ischemia’, which is more common in the elderly and individuals with diabetes mellitus.

    Myocardial Infarction (MI) or heart attack

    One of the most serious complications is a Myocardial Infarction (MI), commonly known as a heart attack. This occurs when there is evidence of myocardial necrosis (heart muscle death) due to acute myocardial ischemia, meaning the heart muscle doesn’t get enough blood flow. A heart attack can be classified as either an ST-segment elevation myocardial infarction (STEMI), a severe type where there’s a complete blockage of a heart artery, or a non-ST-segment elevation myocardial infarction (NSTEMI), where blood flow is severely reduced but not completely blocked. For about half of people, a heart attack is the very first symptom they experience from Coronary Artery Disease, and sadly, half of these initial heart attacks can be fatal. Heart attacks are associated with substantial morbidity and mortality and can even lead to mechanical complications such as acute ventricular septal rupture (a hole in the heart wall), acute mitral regurgitation (a leaky heart valve), or free wall rupture. Previous research also indicates that recurrent heart attacks are linked to worse outcomes than the initial event.

    Sudden Cardiac Death (SCD)

    Another devastating complication is Sudden Cardiac Death (SCD), also known as Cardiac Arrest (CA). In fact, for one out of four people, sudden cardiac death is the very first symptom of coronary artery disease. Coronary artery disease is the most common cause of cardiac arrest, accounting for over 80% of all cases. The prognosis for sudden cardiac arrest remains poor, with a survival rate to hospital discharge typically between 6% and 10%. Many individuals unfortunately die before even reaching the hospital. Even among those successfully resuscitated, there is a high rate of in-hospital mortality. In survivors of cardiac arrest, a post resuscitation syndrome is commonly observed, which frequently includes transient myocardial dysfunction.

    Arrhythmias

    Coronary artery disease can also lead to Arrhythmias, which are irregular heartbeats. For instance, atrial fibrillation, a common type of irregular heartbeat where the upper chambers of the heart beat rapidly and irregularly, is observed in 20% of patients with Coronary artery disease. More severe arrhythmias, such as ventricular tachycardia (a fast, abnormal heart rhythm starting in the lower chambers of the heart), can also occur. These irregular heartbeats can sometimes lead to complications like atrioventricular block or, in the most severe cases, sudden collapse and death.

    Heart failure (HF)

    Heart failure (HF), a condition where the heart cannot pump enough blood to meet the body’s needs, is another common consequence of Coronary artery disease. This often indicates advanced coronary artery disease, perhaps due to a prior heart attack or widespread myocardial fibrosis (scarring of the heart muscle) resulting from previous ischemic episodes.

    In some cases, Coronary artery disease may present with peripheral arterial embolism (a blockage of an artery in the arms or legs) and embolic stroke (a type of stroke caused by a blood clot traveling to the brain), typically following a heart attack where a blood clot forms within the heart’s left ventricle.

    The pervasive impact of Coronary artery disease extends beyond individual health to society at large. Patients with conditions like microvascular angina and vasospastic angina often experience a profound and long-term impact on their physical and mental well-being, leading to repeated hospitalizations and a reduced quality of life. This underscores the critical need for effective prevention and management strategies.

    Other Similar Questions

    How does Coronary artery disease affect the body beyond the heart?

    Coronary artery disease can lead to issues such as peripheral arterial embolism and embolic stroke, usually after a heart attack. It can also contribute to overall decreased quality of life due to chronic symptoms like fatigue and dyspnea.

    Can Coronary artery disease be present without any symptoms?

    Yes, it is possible to have significant myocardial ischemia without experiencing any symptoms, a condition known as ‘silent ischemia.’ This is more common in elderly patients and those with diabetes mellitus.

    Why is it important for family members to be aware of Coronary artery disease complications?

    Because sudden cardiac death can be the first manifestation of Coronary artery disease, and many cases are unexplained even after investigation, family screening for inherited disorders, especially when sudden death occurs before 40-45 years of age, is important to identify at-risk individuals. Awareness of symptoms and risk factors can prompt earlier medical attention.

    Resources

    • Malakar, A. K., Choudhury, D., Halder, B., Paul, P., Uddin, A., & Chakraborty, S. (2019). A review on coronary artery disease, its risk factors, and therapeutics. Journal of Cellular Physiology, 234(10), 16812–16824.
    • Bergmark, B. A., Mathenge, N., Merlini, P. A., Lawrence-Wright, M. B., & Giugliano, R. P. (2021). Acute coronary syndromes. The Lancet, 398(10300), 741–756.
    • Smith, J. N., Negrelli, J. M., Manek, M. B., Hawes, E. M., & Viera, A. J. (2015). Diagnosis and Management of Acute Coronary Syndrome: An Evidence-Based Update. Journal of the American Board of Family Medicine, 28(2), 283–293.
    • Geller, B. J., & Abella, B. S. (2018). Evolving Strategies in Cardiac Arrest Management. Cardiology Clinics, 36(1), 73–84.
    • Granfeldt, A. (2019). In-Hospital Cardiac Arrest. JAMA, 321(16), 1618-1619.
    • Krahn, A. D., Tfelt-Hansen, J., Tadros, R., Steinberg, C., Semsarian, C., & Han, H.-C. (2022). Latent Causes of Sudden Cardiac Arrest. JACC: Clinical Electrophysiology, 8(6), 806–821.
    • Gallone, G., Baldetti, L., Pagnesi, M., Latib, A., Colombo, A., Libby, P., & Giannini, F. (2018). Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome. Journal of the American College of Cardiology, 72(23), 2886–2903.
    • Bahit, M. C., Korjian, S., Daaboul, Y., Baron, S., Bhatt, D. L., Kalayci, A., Chi, G., Nara, P., Shaunik, A., & Gibson, C. M. (2023). Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review. Clinical Therapeutics, 45(9), 1119–1126.
    • Gaviria-Mendoza, A., Zapata-Carmona, J. A., Restrepo-Bastidas, A. A., Betancur-Pulgarín, C. L., & Machado-Alba, J. E. (2020). Prior Use of Medication for Primary Prevention in Patients with Coronary Syndrome. Journal of Primary Care & Community Health, 11, 2150132720946949.
    • Silverio, A., Cancro, F. P., Esposito, L., Bellino, M., D’Elia, D., Verdoia, M., Vassallo, M. G., Ciccarelli, M., Vecchione, C., Galasso, G., & De Luca, G. (2023). Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets. Journal of Clinical Medicine, 12(6), 2161.
    • Fitchett, D. H., Leiter, L. A., Lin, P., Pickering, J., Welsh, R., Stone, J., Gregoire, J., McFarlane, P., Langer, A., Gupta, A., & Goodman, S. G. (2020). Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome. CJC Open, 2(4), 402–415.
    • Isted, A., Williams, R., & Oakeshott, P. (2018). Secondary prevention following myocardial infarction: A clinical update. British Journal of General Practice, 68(669), 151–152.
    • Bavishi, A., Howard, T., Ho-Kim, J., Hiramato, B., Pierce, J. B., Mendapara, P., Alhalel, J., Wu, H.-W., Srdanovich, N., & Stone, N. (2018). Treatment Gap in Primary Prevention Patients Presenting with Acute Coronary Syndrome. The American Journal of Cardiology, 123(2), 237–242.
    • Sun, Z. (2013). Cardiac Imaging Modalities in the Diagnosis of Coronary Artery Disease. Journal of Clinical & Experimental Cardiology, S6(e001), 1–4.
    • Ford, T. J., & Berry, C. (2020). Angina: Contemporary diagnosis and management. Heart, 106(5), 387–398.
    • Libby, P., & Theroux, P. (2005). Pathophysiology of Coronary Artery Disease. Circulation, 111(25), 3481–3488.
    • Mayo Clinic. (n.d.). Coronary artery disease – Diagnosis and treatment. Retrieved from.
    • Albus, C., Barkhausen, J., Fleck, E., Haasenritter, J., Lindner, O., & Silber, S. (2017). The Diagnosis of Chronic Coronary Heart Disease. Deutsches Ärzteblatt International, 114(42), 712–719.
  • What is Cardiac arrest?

    What is Cardiac Arrest?

    Overview

    What is Cardiac Arrest? Cardiac arrest is a sudden and often unexpected event where the heart abruptly stops effectively pumping blood throughout the body. This leads to an immediate loss of circulation, which is why it is so critical.

    Despite extensive research and investment in the field, the outlook for sudden cardiac arrest remains poor, with a survival rate to hospital discharge typically between 6% and 10%. Most people who experience cardiac arrest sadly do not even reach the hospital. Improving outcomes for these patients requires focused efforts at every stage of their care, with heart-related issues being central to this challenge, from before the event occurs, throughout resuscitation, and into the long term follow up for survivors.

    In Details
    What is Cardiac Arrest

    Cardiac arrest is a complex medical emergency. Here’s a quick look at some key aspects:

    • Often caused by pre-existing heart disease.
    • Management involves immediate life support, specialized medical care, and ongoing follow up.
    • Prevention strategies are crucial, both for individuals at high risk and within hospital settings.

    Understanding Cardiac Arrest

    Cardiac arrest is defined as the abrupt and often unanticipated cessation of cardiac output (when the heart stops pumping blood effectively). It is also described as the loss of circulation prompting resuscitation with chest compressions, defibrillation, or both. This means the heart has stopped its vital pumping function, leading to a sudden and complete lack of blood flow to the brain and other organs. If not immediately treated, it can be fatal.

    What Causes Cardiac Arrest?

    Many factors can lead to cardiac arrest:

    • Pre existing heart disease is a common underlying factor.
    • Coronary artery disease (CAD), which affects the blood vessels supplying the heart, is the most common cardiac cause, accounting for over 80% of cases due to heart related issues, especially in men. Acute myocardial ischemia (a lack of blood flow to the heart muscle) is a prominent contributor.
    • Other cardiac causes include structural heart diseases like dilated cardiomyopathy (enlarged heart muscle) or hypertrophic cardiomyopathy (thickened heart muscle), and electrophysiological diseases (conditions affecting the heart’s electrical system) such as Brugada’s syndrome or long QT syndrome. These non-ischemic conditions make up less than 20% of primary cardiac causes.
    • The causes can vary with age; for instance, ischemic cardiomyopathy is more common in patients over 35, while a wider range of causes are seen in those under 35.
    • In hospital cardiac arrest (IHCA), where the event occurs while a patient is in hospital, cardiac causes are still the most frequent (50-60%), followed by respiratory insufficiency (15-40%).
    • Sometimes, despite thorough medical investigation, the cause remains unexplained, partly due to the high mortality before reaching hospital and low autopsy rates.
    • Latent causes (hidden or less obvious causes) are also being increasingly recognised. These include inherited arrhythmia syndromes such as catecholaminergic polymorphic ventricular tachycardia (CPVT), short QT syndrome (SQTS), early repolarization syndrome (ERS), and short-coupled ventricular fibrillation (SCVF). These can account for a significant portion of previously “unexplained” cardiac arrests.

    Can Cardiac Arrest Be Prevented?

    Yes, efforts are made to prevent cardiac arrest:

    • Primary prevention aims to identify high-risk individuals (those with known heart disease) before an event occurs. For some, an implantable cardiac defibrillator (ICD), a small device surgically placed in the body to monitor heart rhythm and deliver an electrical shock if needed, can be used. However, effective tools for identifying at-risk individuals in the general population are still needed.
    • Subacute prevention involves recognizing “warning symptoms,” such as chest pain or shortness of breath, which may appear days or weeks before a cardiac arrest. This suggests that “sudden death is not so sudden” in all cases, potentially allowing for early intervention.
    • In hospitals, prevention includes systems to identify deteriorating patients and the use of rapid response teams. Addressing medication-related issues and managing conditions like sepsis can also help prevent IHCA.
    • Familial screening is also important for first-degree relatives of sudden death victims, especially when the event occurs before age 40-45, to identify inherited heart conditions.

    How is Cardiac Arrest Managed?

    Management of cardiac arrest is divided into “during” and “after” the event:

    • During Cardiac Arrest
      • The core of immediate treatment involves chest compressions, ventilation (providing breaths), and early defibrillation (an electrical shock to reset the heart’s rhythm) if the heart rhythm is “shockable”.
    • For cardiac arrest caused by a heart attack (acute myocardial infarction), an early invasive strategy, such as immediate coronary angiography (a procedure to visualise the heart’s blood vessels) and percutaneous coronary intervention (PCI) (a procedure to open blocked arteries), is often recommended.
    • High-quality and uninterrupted chest compressions are crucial. For laypersons, focusing on compression-only CPR (Cardiopulmonary Resuscitation) is often advised.
    • Medications like epinephrine are commonly used, though their overall long-term benefit is debated. Amiodarone or lidocaine may be used for shock-resistant heart rhythms.
    • Monitoring the quality of CPR using measures like end-tidal carbon dioxide (ETCO2) levels (a measure of carbon dioxide in exhaled breath, reflecting blood flow) is important, with a goal of at least 20 mmHg.
    • For very severe cases, Extracorporeal Membrane Oxygenation (ECMO), a life support system that takes over the function of the heart and lungs, may be considered, especially if a reversible cause for the arrest can be identified.
    • After Cardiac Arrest (Post-resuscitation Care)
      • Once the heart restarts (Return of Spontaneous Circulation ), care focuses on treating the underlying cause, supporting vital organs, and protecting the brain.
      • Postresuscitation myocardial dysfunction (PRMD), a severe but temporary weakening of the heart muscle, is common and usually resolves within 48 to 72 hours. It is managed with medications to support heart function (like dobutamine).
      • For survivors, secondary prevention is vital to prevent future cardiac events. This includes optimizing treatment for existing heart conditions, using medications like beta-blockers, and often implanting an implantable cardiac defibrillator to prevent recurrence of life-threatening arrhythmias.
      • Targeted Temperature Management (TTM), which involves carefully controlling the patient’s body temperature, is a primary strategy to protect the brain, typically maintained between 32°C and 36°C for at least 24 hours.

    Other Similar Questions

    Cardiac arrest vs heart attack?

    A heart attack (acute myocardial infarction) is a common cause of cardiac arrest, but they are not the same event. A heart attack occurs when blood flow to a part of the heart muscle is blocked, while cardiac arrest is when the heart stops pumping blood effectively.

    Can cardiac arrest be prevented?

    Yes, in many cases, by identifying and managing pre-existing heart conditions, recognizing early warning signs, and implementing quick response systems, particularly in hospital settings.

    Resources

    Bougouin, W., & Cariou, A. (2017). Cardiac Issues in Cardiac Arrest. Seminars in Neurology, 37(01), 13–18. Geller, B. J., & Abella, B. S. (2018). Evolving Strategies in Cardiac Arrest Management. Cardiology Clinics, 36(1), 73–84. Andersen, L. W., Holmberg, M. J., Berg, K. M., Donnino, M. W., & Granfeldt, A. (2019). In-Hospital Cardiac Arrest: A Review. JAMA, 321(12), 1200. Krahn, A. D., Tfelt-Hansen, J., Tadros, R., Steinberg, C., Semsarian, C., & Han, H.-C. (2022). Latent Causes of Sudden Cardiac Arrest. JACC: Clinical Electrophysiology, 8(6), 806–821.

  • What causes Coronary Artery disease

    Prevention of Acute coronary syndrome

    Overview

    Preventing acute coronary syndromes, which are serious heart conditions like heart attacks, is incredibly important for living a long and healthy life. Whether you’ve never had a heart event or are recovering from one, understanding the steps you can take is key. This information aims to help you or someone you know to reduce the risk of these life-threatening heart issues. By actively managing risk factors and following medical advice, we can significantly improve health outcomes and reduce the burden of heart disease, which sadly remains the leading cause of death worldwide.

    There are two main types of prevention: primary prevention, which focuses on stopping a heart event from happening in the first place, and secondary prevention, which focuses on preventing future events once someone has already experienced an acute coronary syndrome. Both are crucial for maintaining heart health and improving quality of life.

    In details:

    Quick List for Prevention of Acute Coronary Syndrome

    • Lifestyle modifications
    • Blood pressure control
    • Cholesterol management (lipid-lowering therapy)
    • Diabetes management (glycemic control)
    • Antiplatelet therapy
    • Anticoagulant therapy
    • Beta-blockers
    • Renin-angiotensin system inhibitors (ACE inhibitors/ARBs)
    • Cardiac rehabilitation

    Primary Prevention of Acute Coronary Syndrome

    Primary prevention means taking steps to prevent a heart attack (myocardial infarction) or other acute coronary syndrome from ever occurring. It is about managing existing risk factors and adopting healthy habits to avoid the first event. Key risk factors for heart disease include high cholesterol (known as dyslipidemia), high blood pressure (or hypertension), diabetes mellitus (high blood sugar), obesity, and smoking. The good news is that many of these factors can be changed or controlled through careful attention to your health.

    Lifestyle changes are a powerful tool in primary prevention. Quitting smoking is one of the most impactful steps, as it’s a major risk factor globally and can halve the risk of a heart attack. Eating a healthy diet, such as a “Mediterranean-style” diet rich in fruits, vegetables, and fish, while reducing meat and saturated fats, is recommended. Regular physical activity, aiming for 20-30 minutes of exercise daily to the point of slight breathlessness, is also vital. Additionally, maintaining a healthy weight is crucial for heart health.

    Beyond lifestyle, medications play a significant role in primary prevention for those at higher risk. Statins, which are medicines that lower cholesterol levels, are recommended based on an individual’s overall risk of developing atherosclerotic cardiovascular disease (ASCVD), a condition where plaque builds up in the arteries. Despite their known benefits, studies show that a notable number of people who later suffer their first acute coronary event were actually eligible for statin therapy but hadn’t started it. For example, in one study, 85% of patients with calculable heart risk needed statins for primary prevention, but only about two-thirds received them, often not at the right dose. Common statins include atorvastatin.

    The use of aspirin for primary prevention is still debated and should be carefully considered with your doctor, weighing the potential benefits against risks like bleeding. Controlling high blood pressure with prescribed medications is another essential step. It’s important to work with your healthcare provider to ensure your blood pressure is within target ranges. For those with diabetes, effective management is critical, but achieving optimal blood sugar control (measured by glycated hemoglobin or HbA1c) can sometimes be challenging for patients who go on to experience heart events. Lastly, your doctor can calculate your cardiovascular risk score to help identify if you would benefit from preventive medications, though sometimes there isn’t enough information in medical records for a full assessment.

    Secondary Prevention of Acute Coronary Syndrome

    Secondary prevention refers to the measures taken after someone has already experienced an acute coronary syndrome, such as a heart attack, to prevent future heart attacks, strokes, or other cardiovascular complications. Patients who have had an acute coronary syndrome are at a significantly higher risk of having another event. Therefore, aggressive and sustained management is essential.

    One of the cornerstones of secondary prevention is dual antiplatelet therapy (DAPT). This involves taking two types of medicines that prevent blood clots: aspirin, which should be started immediately and continued for life (unless you can’t tolerate it, in which case a different antiplatelet like clopidogrel may be used), and a P2Y12 inhibitor. P2Y12 inhibitors, such as ticagrelor or prasugrel, are generally preferred over clopidogrel and are recommended for 12 months in most patients after an acute coronary syndrome. For patients at a very high risk of future heart events (for example, those with diabetes, kidney disease, peripheral artery disease, or disease in multiple heart arteries) and a low risk of bleeding, this dual therapy might be continued for longer than 12 months. However, this extended duration does increase the risk of bleeding. Conversely, if a patient has a high risk of bleeding, a shorter duration of DAPT (e.g., 6 months) might be recommended by their heart specialist.

    In certain high-risk individuals, combining an antiplatelet with a low dose of an anticoagulant (a medicine to prevent blood clots) like rivaroxaban has been shown to reduce cardiovascular events, particularly in those with stable atherosclerotic vascular disease who have had a previous heart attack. It’s important to remember that this combination also carries an increased risk of bleeding.

    Intensive lipid-lowering therapy is another critical component. This begins with prescribing high-intensity statins for all patients immediately after a heart attack, regardless of their initial cholesterol levels. If the target level of “bad cholesterol” (low-density lipoprotein cholesterol or LDL-C) is not reached (e.g., below 1.4 mmol/L) within 4-6 weeks, additional medications like ezetimibe should be added. If the LDL-C goal is still not achieved, PCSK9 inhibitors, such as evolocumab or alirocumab, may be introduced. These are powerful medicines that significantly reduce LDL-C and the risk of cardiovascular events. The aim is to lower LDL-C as much as possible with the maximum tolerated therapy.

    Additionally, neurohormonal agents are a standard part of secondary prevention. Beta-blockers are typically started within 24 hours of the event if there are no reasons not to, and usually continued for at least three years. These medicines help reduce the heart’s workload. Medications that modify the renin-angiotensin aldosterone system (RAAS), such as ACE inhibitors or angiotensin receptor blockers (ARBs), are given within 24 hours to patients with certain conditions like fluid in the lungs (pulmonary congestion) or reduced heart pumping capacity. Aldosterone antagonists are recommended for specific patients with heart failure and diabetes who are already on ACE inhibitors/ARBs and beta-blockers.

    New areas of focus in secondary prevention include targeting inflammation. Chronic inflammation is increasingly recognized as a key factor in heart disease and recurrent events. Medications like colchicine, traditionally used for gout, have shown some promise in reducing major adverse cardiovascular events after a recent heart attack, though more research is needed.

    Elevated triglycerides can also be addressed with specific treatments, such as icosapent ethyl, which has been shown to reduce cardiovascular events even when patients are already on statins. Furthermore, for patients with Type 2 diabetes, certain glucose-lowering agents have been found to reduce cardiovascular events and even mortality, independent of their effects on blood sugar.

    Finally, adherence to these long-term therapies is paramount for success. Studies show that many patients stop taking their medicines over time, with nearly 30% discontinuing one or more within 90 days of their acute coronary syndrome. Factors influencing adherence can be complex, including a patient’s understanding of their condition, their mood (e.g., depression), and how well the healthcare system supports them with early follow-up and ongoing education. Therefore, a comprehensive approach involving patient education and active engagement from healthcare providers is key to improving outcomes.

    Other similar questions

    What is acute coronary syndrome?

    It is a group of heart conditions that includes unstable angina (chest pain without heart muscle damage) and myocardial infarction (a heart attack where heart muscle damage occurs, classified as ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction)

    What causes a heart attack?

    Most commonly, it is caused by a sudden blockage in one of the heart’s arteries, usually due to a blood clot forming on a damaged or ruptured plaque (a fatty deposit) inside the artery wall.

    How are heart attacks diagnosed?

    Diagnosis typically relies on the patient’s symptoms (such as chest pain), changes seen on an electrocardiogram (ECG), and blood tests that measure markers of heart muscle injury, like troponin. Modern high-sensitivity troponin tests allow for rapid and accurate diagnosis.

    Resources

    • Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022 Apr 2;399(10332):1347-1358. doi: 10.1016/S0140-6736(21)02391-6. PMID: 35367005; PMCID: PMC8970581.
    • Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015 Mar-Apr;28(2):283-93. doi: 10.3122/jabfm.2015.02.140189. PMID: 25748771.
    • Bahit MC, Korjian S, Daaboul Y, Baron S, Bhatt DL, Kalayci A, Chi G, Nara P, Shaunik A, Gibson CM. Patient Adherence to Secondary Prevention Therapies After an Acute Coronary Syndrome: A Scoping Review. Clin Ther. 2023 Nov;45(11):1119-1126. doi: 10.1016/j.clinthera.2023.08.011. Epub 2023 Sep 9. PMID: 37690915.
    • Gallone G, Baldetti L, Pagnesi M, Latib A, Colombo A, Libby P, Giannini F. Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome: JACC State-of-the-Art Review. J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2886-2903. doi: 10.1016/j.jacc.2018.09.052. PMID: 30522652.
    • Gaviria-Mendoza A, Zapata-Carmona JA, Restrepo-Bastidas AA, Betancur-Pulgarín CL, Machado-Alba JE. Prior Use of Medication for Primary Prevention in Patients with Coronary Syndrome. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720946949. doi: 10.1177/2150132720946949. PMID: 32755281; PMCID: PMC7543101.
    • Silverio, A.; Cancro, F.P.; Esposito, L.; Bellino, M.; D’Elia, D.; Verdoia, M.; Vassallo, M.G.; Ciccarelli, M.; Vecchione, C.; Galasso, G.; et al. Secondary Cardiovascular Prevention after Acute Coronary Syndrome: Emerging Risk Factors and Novel Therapeutic Targets. J. Clin. Med. 2023, 12, 2161. https://doi.org/10.3390/jcm12062161
    • Fitchett DH, Leiter LA, Lin P, Pickering J, Welsh R, Stone J, Gregoire J, McFarlane P, Langer A, Gupta A, Goodman SG. Update to Evidence-Based Secondary Prevention Strategies After Acute Coronary Syndrome. CJC Open. 2020 Apr 10;2(5):402-415. doi: 10.1016/j.cjco.2020.04.002. PMID: 32995726; PMCID: PMC7499366.
    • Isted A, Williams R, Oakeshott P. Secondary prevention following myocardial infarction: a clinical update. Br J Gen Pract. 2018 Mar;68(668):151-152. doi: 10.3399/bjgp18X695261. PMID: 29472228; PMCID: PMC5819978.

  • Treatment and Management of Acute Coronary Syndrome

    Treatment and Management of Acute Coronary Syndrome

    Understanding the treatment and management of Acute Coronary Syndrome (ACS) is vital because it explains the steps taken to address these serious heart conditions and prevent future problems. The goal is to restore blood flow to the heart muscle quickly, minimize damage, and improve long-term health.

    Overview

    The treatment and management of Acute Coronary Syndrome focus on prompt restoration of blood flow, typically through procedures like coronary revascularization (opening blocked arteries), alongside a combination of medications to prevent blood clots and support heart function. Long-term management, known as secondary prevention, is equally crucial, involving ongoing medication and significant lifestyle changes to reduce the risk of future heart events.

    The approach to managing Acute Coronary Syndrome is personalized, taking into account the specific type of Acute Coronary Syndrome, the patient’s individual risk factors, and other health conditions.

    In Details

    First, here’s a quick list of the main treatment and management strategies for Acute Coronary Syndrome:

    • Immediate Assessment and Risk Stratification
    • Coronary Revascularization (e.g., Percutaneous Coronary Intervention (PCI), Fibrinolysis)
    • Antiplatelet Therapy (e.g., Aspirin, P2Y12 inhibitors like Clopidogrel, Prasugrel, Ticagrelor)
    • Anticoagulation Therapy
    • Adjuvant Medications (e.g., Beta-blockers)
    • Lipid-Lowering Therapy (e.g., Statins)
    • Secondary Prevention (Lifestyle modifications)
    • Management in Special Populations (e.g., Women, Elderly, Patients with COVID-19, those in Low- and Middle-Income Countries)

    Initial management of Acute Coronary Syndrome

    The diagnosis and initial management of Acute Coronary Syndrome begin with a thorough clinical assessment, including a patient’s symptoms, an electrocardiogram (ECG) (a test that records the electrical activity of the heart), and cardiac troponin levels (blood tests that detect proteins released when heart muscle is damaged). These steps help determine the type of ACS and the urgency of treatment. For instance, ST-segment elevation myocardial infarction (STEMI), a severe type of heart attack, is identified by specific ECG changes and requires immediate attention. Prompt evaluation is crucial to prevent potentially fatal outcomes and relieve ongoing lack of oxygen to the heart.

    Coronary Revascularization

    A key treatment strategy for Acute Coronary Syndrome is coronary revascularization, which aims to reopen blocked or severely narrowed coronary arteries. For patients experiencing a ST-segment elevation myocardial infarction, immediate reperfusion therapy (restoring blood flow) is the top priority, ideally within 12 hours of symptom onset. The preferred method is Percutaneous Coronary Intervention (PCI), often called angioplasty and stenting, which involves inserting a balloon and usually a stent (a small mesh tube) to open the artery. The goal is to perform PCI within 60-90 minutes of the first medical contact. If timely PCI is not available (e.g., if a patient is far from a PCI-capable hospital), fibrinolysis (clot-busting medication) is given within 30 minutes of hospital arrival to dissolve the blood clot. For non-ST-segment elevation acute coronary syndrome patients, the timing of an invasive procedure like angiography (an X-ray of the heart’s arteries) and possible PCI depends on their risk.

    Those at very high risk (e.g., unstable blood pressure, ongoing chest pain, life-threatening irregular heartbeats) need emergent angiography within 2 hours. In stable ST-segment elevation myocardial infarction patients with blockages in multiple arteries, opening all significant blockages (complete revascularization) may improve outcomes, but in those with cardiogenic shock (when the heart cannot pump enough blood to meet the body’s needs), only the main blocked artery should be treated immediately.

    Antiplatelet therapy

    Antiplatelet therapy is a cornerstone of Acute Coronary Syndrome management, working to prevent blood clots by stopping platelets (tiny blood cells that help blood clot) from sticking together. Aspirin should be started as soon as possible after an Acute Coronary Syndrome event and continued indefinitely. In addition to aspirin, a P2Y12 inhibitor is typically added. Common P2Y12 inhibitors include clopidogrel, prasugrel, and ticagrelor. These are usually given for at least 12 months in most patients, as this dual antiplatelet therapy (DAPT) has been shown to reduce future heart problems. While prasugrel and ticagrelor are generally preferred over clopidogrel due to their stronger effects, they also carry a higher risk of bleeding. The choice of agent and duration of dual antiplatelet therapy are carefully considered based on a patient’s individual risk of both clotting and bleeding. Recent studies are also exploring if aspirin can be stopped earlier in some high-bleeding-risk patients after a few months of dual antiplatelet therapy, without increasing the risk of clotting.

    Anticoagulation therapy

    Anticoagulation therapy, which uses medications to thin the blood and prevent new clots from forming or existing clots from growing, is also critical in the initial management of Acute Coronary Syndrome. Parenteral (injected) anticoagulants, such as unfractionated heparin, low-molecular-weight heparin, fondaparinux, or bivalirudin, are used alongside antiplatelet agents during the acute phase. For patients who also have conditions requiring long-term blood thinners, such as atrial fibrillation (an irregular heart rhythm), the combination of dual antiplatelet therapy and an oral anticoagulant requires careful balance due to an increased risk of bleeding. New oral anticoagulants have been studied in this setting, but while some reduce cardiovascular events, they generally increase bleeding risk and are not yet broadly approved for ACS prevention in Europe or the US.

    Adjuvant medications

    Beyond these immediate interventions, adjuvant medications play a crucial role in long-term management and secondary prevention. Beta-blockers are usually started within 24 hours of Acute Coronary Syndrome if there are no contraindications, as they help reduce the heart’s workload and oxygen demand. They are typically continued long-term, though the exact duration is debated. Renin-angiotensin system inhibitors (ACE inhibitors or ARBs) are recommended for patients with specific conditions like heart failure or reduced pumping function of the heart (ejection fraction below 40%), as they can reduce mortality. Aldosterone antagonists are also beneficial for certain heart failure patients with reduced ejection fraction and diabetes.

    Lipid-lowering therapy

    Lipid-lowering therapy is fundamental for preventing future heart events. All patients with Acute Coronary Syndrome should start or continue high-intensity statin therapy to aggressively lower LDL-cholesterol (LDL-C), often called “bad cholesterol”. If the LDL-C target (e.g., less than 1.4 mmol/L) is not reached with statins alone, additional medications like ezetimibe and then PCSK9 inhibitors may be added. These therapies are critical even if initial cholesterol levels seem acceptable, as reducing LDL-C significantly impacts cardiovascular risk. While inflammation is known to contribute to Acute Coronary Syndrome, anti-inflammatory therapies like colchicine have shown mixed results in trials and are not currently broadly recommended by major guidelines.

    Secondary prevention

    Finally, secondary prevention for Acute Coronary Syndrome patients is crucial and involves both medication and lifestyle modifications. This includes dietary changes, regular exercise, quitting smoking, and participating in cardiac rehabilitation programmes. These measures, combined with adherence to long-term medications, are vital for reducing the risk of recurrent events and improving overall quality of life.

    It’s important to recognize that the management of Acute Coronary Syndrome can be complicated by factors such as COVID-19, which can directly injure the heart, increase clot risk, and disrupt healthcare systems. Additionally, sex- and race-based disparities exist, with women and certain racial groups sometimes experiencing delays in diagnosis, less frequent revascularization, and lower rates of receiving guideline-recommended medications. Older patients and those in low- and middle-income countries also face unique challenges and disparities in Acute Coronary Syndrome care.

    Other Similar Questions

    Resources

    • Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022 Apr 2;399(10332):1347-1358. doi: 10.1016/S0140-6736(21)02391-6. PMID: 35367005; PMCID: PMC8970581.
    • Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015 Mar-Apr;28(2):283-93. doi: 10.3122/jabfm.2015.02.140189. PMID: 25748771.
  • Atherosclerosis and Plaque formation Plaque rupture or erosion Thrombus (blood clot) formation Reduced blood flow leading to myocardial ischemia Heart muscle damage or death, resulting in myocardial infarction Other causes, such as supply-demand mismatch (Type 2myocardial infarction), Spontaneous Coronary Artery Dissection (SCAD), or Myocardial Infarction with No Obstructive Coronary Artery Disease.

    Causes of Acute Coronary Syndrome

    Understanding The Causes of Acute Coronary Syndrome, is crucial for both patients and their loved ones. It helps explain why the heart acts the way it does during these serious conditions and highlights why quick action and ongoing care are so important.

    Overview

    The Causes of Acute Coronary Syndrome (ACS) describes conditions where there’s a sudden, severe reduction in blood flow to the heart muscle. This lack of blood flow means the heart muscle isn’t getting enough oxygen, a condition called myocardial ischemia. If this ischemia is severe or lasts too long, it can lead to myocardial infarction (MI), commonly known as a heart attack, where heart muscle cells are damaged or die. The primary cause of Acute Coronary Syndrome is usually a sudden blockage or severe narrowing in the heart’s arteries.

    The core problem often stems from atherosclerosis, a process where fatty deposits build up in the artery walls. When these deposits become unstable, they can trigger the body’s clotting system, forming a blood clot that severely restricts or completely blocks blood flow, leading to the symptoms and damage associated with Acute Coronary Syndrome. It’s important to understand that while this is the most common cause, there are other ways the heart muscle can be injured in Acute Coronary Syndrome.

    In Details : The Causes of Acute Coronary Syndrome

    First, here’s a quick list of the main mechanisms involved in the pathophysiology of Acute Coronary Syndrome

    • Atherosclerosis and Plaque formation
    • Plaque rupture or erosion
    • Thrombus (blood clot) formation
    • Reduced blood flow leading to myocardial ischemia
    • Heart muscle damage or death, resulting in myocardial infarction
    • Other causes, such as supply-demand mismatch (Type 2myocardial infarction), Spontaneous Coronary Artery Dissection (SCAD), or Myocardial Infarction with No Obstructive Coronary Artery Disease.

    The most common way Acute Coronary Syndrome develops is linked to atherosclerosis. This is a long-term process where the heart’s arteries, which are usually smooth and open, become stiff and narrow due to the build-up of fatty deposits, cholesterol, and other substances forming what’s called plaque. When this plaque becomes unstable, it can either rupture (break open) or erode (wear away). When this happens, the body’s natural response is to try and “fix” the injury by forming a thrombus, which is a blood clot, over the damaged area.

    This blood clot can suddenly block the artery, significantly reducing or completely stopping the blood flow to a part of the heart muscle. This sudden lack of oxygen and nutrients is what causes myocardial ischemia, leading to symptoms like chest pain. If the blockage isn’t quickly resolved, the heart muscle cells deprived of oxygen begin to die, leading to a myocardial infarction, or heart attack. This process is known as Type 1 myocardial infarction, which is usually what people refer to when they talk about a “heart attack”.

    However, not all heart attacks are caused by a sudden clot from plaque rupture or erosion. Sometimes, a heart attack, classified as Type 2 myocardial infarction, occurs due to a severe imbalance between the heart’s oxygen supply and its demand, without a direct sudden plaque-related blockage. This can happen if the heart needs a lot more oxygen (e.g., during extreme stress or a very fast heart rate) or if the body’s oxygen supply is critically low (e.g., from severe anemia or very low blood pressure). Other less common causes of Acute Coronary Syndrome include Spontaneous Coronary Artery Dissection, which is when a tear occurs in the wall of a coronary artery, creating a false channel that squeezes the main blood vessel and reduces blood flow. Another scenario is Myocardial Infarction with No Obstructive Coronary Artery Disease, where a heart attack is diagnosed, but angiography (a special X-ray of the heart’s arteries) doesn’t show significant blockages.

    Furthermore, recent insights indicate that infections like COVID-19 can also contribute to Acute Coronary Syndrome by causing direct or indirect inflammation and injury to the heart muscle, or by increasing the risk of blood clots. Understanding these different mechanisms is vital because treatment strategies may vary depending on the underlying cause.

    Other Similar Questions

    Resources

    • Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022 Apr 2;399(10332):1347-1358. doi: 10.1016/S0140-6736(21)02391-6. PMID: 35367005; PMCID: PMC8970581.
    • Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015 Mar-Apr;28(2):283-93. doi: 10.3122/jabfm.2015.02.140189. PMID: 25748771.
  • How Acute Coronary Syndrome (ACS) Is Diagnosed

    The Diagnosis of Acute Coronary Syndrome?

    When diagnosing Acute Coronary Syndrome (ACS), medical professionals rely on a combination of factors to understand what is happening with a patient’s heart. It’s a critical process because timely and accurate diagnosis leads to the best possible treatment.

    Overview

    Acute Coronary Syndrome (ACS) is a term used to describe a range of serious heart conditions where there is a sudden reduction in blood flow to the heart muscle, leading to myocardial ischemia (lack of oxygen to the heart muscle). This can manifest as unstable angina (chest pain due to reduced blood flow, but no heart muscle damage) or a heart attack (myocardial infarction or MI), which involves actual damage or death of heart muscle cells.

    The diagnosis of Acute Coronary Syndrome primarily involves a careful look at three key areas: a patient’s symptoms, the results of an electrocardiogram (ECG), and specific blood tests that measure markers of heart muscle damage, known as cardiac troponins. These elements help doctors determine the type of Acute Coronary Syndrome and the best course of action.

    In Detail : The Diagnosis of Acute Coronary Syndrome

    First, here’s a quick list of the main components used to diagnose ACS:

    •Clinical Presentation (Symptoms)

    •Electrocardiogram (ECG) Findings

    •Cardiac Troponin Levels (Blood Tests)

    Second, let’s explore these in more detail:

    1. Clinical Presentation (Symptoms):

    When a patient might be experiencing Acute Coronary Syndrome, doctors first consider their symptoms. The most common symptom is chest pain, but this can also appear as discomfort in other areas like the upper arm, jaw, or upper stomach. Other common symptoms include shortness of breath (dyspnea), sweating (diaphoresis), nausea, unusual fatigue, or fainting (syncope). It’s important to know that these symptoms can occur with physical effort or even at rest, and the pain is often spread out rather than in one specific spot. It is also important to note that women, older patients, and those with diabetes may experience atypical symptoms like palpitations (a feeling of a racing or pounding heart), or even present without any symptoms at all. A thorough review of a patient’s past medical history, including any prior heart conditions or risk factors, is also crucial.

    2. Electrocardiogram (ECG) Findings:

    An ECG is a simple and quick test that records the electrical activity of the heart. Doctors look for specific changes in the ECG pattern that can indicate if the heart muscle is experiencing a lack of blood flow. The most significant finding is ST-segment elevation, which is a classic sign of a severe type of heart attack called ST-elevation myocardial infarction (STEMI). If there are no persistent ST-segment elevations, but other signs point to Acute Coronary Syndrome, it’s generally classified as non-ST-segment elevation acute coronary syndrome. It’s crucial to remember that ECG changes alone might not always be enough for a definitive diagnosis, as other conditions can sometimes cause similar ECG abnormalities.

    3. Cardiac Troponin Levels:

    These are specific blood tests that measure proteins released into the bloodstream when heart muscle cells are damaged. Cardiac troponin (specifically troponin I or T) is the preferred marker because it is highly sensitive and specific to heart muscle injury. A diagnosis of a heart attack (MI) requires evidence of this heart muscle damage, typically shown by a rise and/or fall in troponin levels. Doctors measure troponin levels when symptoms first appear and again a few hours later (e.g., 1-3 hours later) to see if the levels are increasing, which helps confirm ongoing heart damage. High-sensitivity troponin (hsTn) assays are advanced tests that can detect very small amounts of troponin earlier, allowing for quicker “rule-out” or “rule-in” of a heart attack. However, it’s important to note that elevated troponin can also be caused by other medical conditions not related to Acute Coronary Syndrome, such as heart failure or kidney disease, so it’s not used in isolation for diagnosis.

    Other Similar Questions

    What is Acute Coronary Syndrome?

    Acute Coronary Syndrome is a broad term for conditions where there’s a sudden, severe reduction in blood flow to the heart, which can lead to a heart attack or unstable chest pain

    What are the main types of Acute Coronary Syndrome?

    The main types are unstable angina (chest pain without heart damage), non-ST-elevation myocardial infarction (NSTEMI) (a heart attack without specific ECG changes), and ST-elevation myocardial infarction (STEMI) (a severe heart attack with distinct ECG changes)

    Why is early diagnosis important?

    Early diagnosis is absolutely vital because it allows for prompt treatment to restore blood flow to the heart, which can prevent further damage, save heart muscle, and ultimately improve outcomes and prevent potentially fatal consequences

    Can other conditions cause similar symptoms?

    Yes, conditions like inflammation around the heart (pericarditis), a tear in the main artery (dissecting aortic aneurysm), lung problems like a pulmonary embolism, or even anxiety can cause symptoms similar to Acute Coronary Syndrome

    Resources

    • Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022 Apr 2;399(10332):1347-1358. doi: 10.1016/S0140-6736(21)02391-6. PMID: 35367005; PMCID: PMC8970581.
    • Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015 Mar-Apr;28(2):283-93. doi: 10.3122/jabfm.2015.02.140189. PMID: 25748771.
  • types of Acute Coronary Syndrome

    What is Acute Coronary Syndrome? (ACS)

    Overview

    For patients, and those who care for them, it’s vital to understand Acute Coronary Syndrome (ACS). This term acts as an umbrella for a group of serious heart conditions where there is a sudden and significant reduction in blood flow to your heart muscle. Think of it like a plumbing problem in your heart’s blood supply. When the heart doesn’t get enough oxygen-rich blood, it can become damaged, leading to symptoms like chest pain.

    The importance of understanding ACS lies in its potential severity: it’s associated with substantial illness, disability, and can even be life-threatening. Recognizing the signs and seeking immediate medical attention is crucial, as prompt diagnosis and treatment can significantly improve outcomes and reduce the burden on both patients and the healthcare system.

    In Details

    First, Acute Coronary Syndrome includes three main types:

    • Unstable Angina (UA)
    • Non-ST Elevated Myocardial Infarction (NSTEMI)
    • ST-Elevated Myocardial Infarction (STEMI)

    Second, let’s break down these conditions. At its core, Acute Coronary Syndrome involves myocardial ischemia, which simply means that your heart muscle isn’t getting enough blood flow. This reduced blood flow can cause symptoms and, if severe enough, lead to myocardial necrosis, which is the death of heart muscle cells.

    •Unstable Angina (UA) is considered the least severe form of ACS. If you experience Unstable Angina, you will have symptoms suggesting a heart problem, most commonly chest pain, but blood tests for heart damage, known as cardiac biomarkers (like troponin), will not be elevated. Also, any changes seen on your Electrocardiogram (ECG) – a test that records your heart’s electrical activity – will only be temporary. This means your heart muscle is “crying out” for blood, but it hasn’t yet suffered irreversible damage.

    •Myocardial Infarction (MI), often called a heart attack, means that part of your heart muscle has actually died due to a lack of blood flow. This is confirmed by a rise and/or fall in cardiac troponin levels (or other biomarkers), which are specific proteins released into the bloodstream when heart muscle is damaged. Myocardial Infarctions are further categorized based on specific findings on the ECG:

    ◦ Non-ST Elevated Myocardial Infarction (NSTEMI): With NSTEMI, the blood tests show heart muscle damage, but your ECG does not show persistent ST segment elevation. ST segment elevation is a particular pattern on the ECG that indicates a complete blockage of a major heart artery.

    ◦ ST-Elevated Myocardial Infarction (STEMI): This is generally the most serious type of heart attack because it usually means a major coronary artery is completely blocked. The key distinguishing feature is a persistent ST segment elevation on the ECG, alongside evidence of heart muscle damage from blood tests. This type of heart attack often requires immediate emergency procedures to restore blood flow.

    It’s also important to note that while the most common cause of MI (called Type 1 myocardial infarction) is a blockage from a ruptured or eroded plaque in the coronary arteries, heart muscle injury or infarction can also happen due to other reasons. For example, Type 2 myocardial infarction occurs from an imbalance between the heart’s oxygen supply and demand, not necessarily from a sudden blockage. There are also specific situations like Myocardial Infarction with No Obstructive Coronary Artery Disease, where a heart attack occurs without significant blockages in the main arteries, and Spontaneous Coronary Artery Dissection (SCAD), which is a rare condition where a tear forms in the wall of a heart artery.

    Other similar questions

    Is Acute Coronary Syndrome the same as a heart attack?

    No, a heart attack (Myocardial Infarction) is a type of Acute Coronary Syndrome. Acute Coronary Syndrome is a broader term that encompasses unstable angina, Non-ST Elevated Myocardial Infarction (NSTEMI), and ST-Elevated Myocardial Infarction (STEMI).

    What are the common symptoms of Acute Coronary Syndrome?

    Typical symptoms include chest pain, discomfort in the upper limbs, jaw, or stomach, shortness of breath, sweating, or feeling sick. However, some people, like women, older individuals, or those with diabetes, might experience less typical symptoms

    How do doctors diagnose Acute Coronary Syndrome?

    Diagnosis involves evaluating your symptoms, checking your ECG, and performing blood tests to measure cardiac biomarkers like troponin

    Resources

    • Bergmark BA, Mathenge N, Merlini PA, Lawrence-Wright MB, Giugliano RP. Acute coronary syndromes. Lancet. 2022 Apr 2;399(10332):1347-1358. doi: 10.1016/S0140-6736(21)02391-6. PMID: 35367005; PMCID: PMC8970581.
    • Smith JN, Negrelli JM, Manek MB, Hawes EM, Viera AJ. Diagnosis and management of acute coronary syndrome: an evidence-based update. J Am Board Fam Med. 2015 Mar-Apr;28(2):283-93. doi: 10.3122/jabfm.2015.02.140189. PMID: 25748771.